751 - 760 of 7942 Results
Title
Year
-
RESTRICTEDTitle: PTPA variants are rare in early-onset and familial Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 146Issue #: 12Start Page: e125End Page: e127Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1093/brain/awad244Citation Count: 1
- Antipsychotic drug efficacy correlates with the modulation of D1 rather than D2 receptor-expressing striatal projection neurons2023OPENTitle: Antipsychotic drug efficacy correlates with the modulation of D1 rather than D2 receptor-expressing striatal projection neuronsJournal Name: Nature NeurosciencePublisher: Springer Science and Business Media LLCVol: 26Issue #: 8Start Page: 1417End Page: 1428Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41593-023-01390-9Citation Count: 32
-
OPENTitle: Cerebral chemoarchitecture shares organizational traits with brain structure and functionJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.83843Best OA location URL: https://doi.org/10.7554/elife.83843Citation Count: 8
- Different pieces of the same puzzle: a multifaceted perspective on the complex biological basis of Parkinson’s disease2023RESTRICTEDTitle: Different pieces of the same puzzle: a multifaceted perspective on the complex biological basis of Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-023-00535-8Best OA location URL: https://www.nature.com/articles/s41531-023-00535-8.pdfCitation Count: 9
- Safety, tolerability, and preliminary efficacy of SYN120, a dual 5-HT6/5-HT2A antagonist, for the treatment of Parkinson disease dementia: A randomized, controlled, proof-of-concept trial2023RESTRICTEDTitle: Safety, tolerability, and preliminary efficacy of SYN120, a dual 5-HT6/5-HT2A antagonist, for the treatment of Parkinson disease dementia: A randomized, controlled, proof-of-concept trialJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 114Issue #:Start Page: 105511End Page: 105511Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2023.105511Citation Count: 2
- Spatially heterogeneous structure-function coupling in haemodynamic and electromagnetic brain networks2023OPENTitle: Spatially heterogeneous structure-function coupling in haemodynamic and electromagnetic brain networksJournal Name: NeuroImagePublisher: Elsevier BVVol: 278Issue #:Start Page: 120276End Page: 120276Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.neuroimage.2023.120276Best OA location URL: https://doi.org/10.1016/j.neuroimage.2023.120276Citation Count: 5
-
OPENTitle: Two distinct trajectories of clinical and neurodegeneration events in Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-023-00556-3Best OA location URL: https://www.nature.com/articles/s41531-023-00556-3.pdfCitation Count: 16
- Artificial intelligence–coupled plasmonic infrared sensor for detection of structural protein biomarkers in neurodegenerative diseases2023OPENTitle: Artificial intelligence–coupled plasmonic infrared sensor for detection of structural protein biomarkers in neurodegenerative diseasesJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 9Issue #: 28Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1126/sciadv.adg9644Best OA location URL: https://www.science.org/doi/pdf/10.1126/sciadv.adg9644?download=trueCitation Count: 31
- Elevated ApoE, ApoJ and lipoprotein-bound α-synuclein levels in cerebrospinal fluid from Parkinson's disease patients – Validation in the BioFIND cohort2023OPENTitle: Elevated ApoE, ApoJ and lipoprotein-bound α-synuclein levels in cerebrospinal fluid from Parkinson's disease patients – Validation in the BioFIND cohortJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 116Issue #:Start Page: 105765End Page: 105765Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2023.105765Best OA location URL: http://www.prd-journal.com/article/S1353802023008441/pdfCitation Count: 2
- Neuroinflammation and Mitochondrial Dysfunction in Parkinson’s Disease: Connecting Neuroimaging with Pathophysiology2023RESTRICTEDTitle: Neuroinflammation and Mitochondrial Dysfunction in Parkinson’s Disease: Connecting Neuroimaging with PathophysiologyJournal Name: AntioxidantsPublisher: MDPI AGVol: 12Issue #: 7Start Page: 1411End Page: 1411Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.3390/antiox12071411Best OA location URL: https://www.mdpi.com/2076-3921/12/7/1411/pdf?version=1689141105Citation Count: 3